from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0604/lpqO

LFCtreatmentdescriptionclass of inhibitor

0.750

Amikacinug/mL Amikacintranslation

0.725

Cap5-10ug/mL Capreomycintranslation

0.772

Rox10-50 ug/mL Roxithromycintranslation

0.287

SM2-5 ug/mL Streptomycintranslation

1.987

Tet5-10 ug/mL Tetracyclinetranslation

1.137

Rif0.2-5ug/mL Rifampicintranscription

0.728

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.938

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.388

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.890

CPZ10-50 ug/mL Chlorpromazinerespiration

0.605

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.516

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.281

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.173

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.296

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.300

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.534

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.666

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.847

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.930

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.472

KCN5-20 ug/mL Potassium cyaniderespiration

0.489

NaN30.2-2 mM Sodium aziderespiration

-0.708

Nigericin50 uM Nigericinrespiration

-0.038

TRC10-150 ug/mL Triclosanrespiration

-0.252

TRZ10-25 ug/mL Thioridazinerespiration

-1.696

Valinomycin0.5-10 uM Valinomycinrespiration

0.073

ZnSO42 mM ZnSO4respiration

-1.038

menadione6-10 ug/mL Menadionerespiration

0.077

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.226

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.292

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.601

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.479

NRP_1Non-replicating persistence stage 1dosRassociated

-0.121

Amp0.2mg/mL AmpicillincellWall

-0.424

Cephalexin20-100 ug/mL CephalexincellWall

-0.074

Cerulenin0.32-5 ug/mL CerulenincellWall

0.453

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.251

EMB10-20 ug/mL EthambutolcellWall

0.309

Eta12-40 ug/mL EthionamidecellWall

0.130

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.286

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.898

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.330

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.885

BZA0.12 mg/mL BenzamidearomaticAmides

0.442

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.443

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.243

H2O24 mM hydrogen peroxideDNAdamaging

0.660

Levo10 ug/mL LevofloxacinDNAdamaging

0.426

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.030

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.140

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.356

UVUV-irradiationDNAdamaging

0.070

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.338

Antimycin12.5-50 ug/mL Antimycin A?

-0.760

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.200

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.422

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.337

PA8240.2-2 ug/mL PA-824?

-1.383

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.160

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.259

Verapamil50 uM Verapamil?

-0.465

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.323

methoxatin10-20 ug/mL Methoxatin?